(Q73213291)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9098680%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Tremulous jaw movements induced by the acetylcholinesterase inhibitor tacrine: effects of antiparkinsonian drugs (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9098680%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9098680%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

M S Cousins

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9098680%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

D L Carriero

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9098680%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

language of work or name

English

0 references

publication date

1 March 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9098680%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Pharmacology

2 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9098680%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

322

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9098680%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

2-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9098680%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

137-145

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9098680%20AND%20SRC:MED&resulttype=core&format=json

Vacuous jaw movements in rats induced by acute reserpine administration: interactions with different doses of apomorphine

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900008-3

Repeated scopolamine injections sensitize rats to pilocarpine-induced vacuous jaw movements and enhance striatal muscarinic receptor binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900008-3

D2 dopamine receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in rat striatum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900008-3

D1 and D2 dopaminergic regulation of acetylcholine release from striata of freely moving rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900008-3

Dopamine depletion preferentially impairs D1- over D2-receptor regulation of striatal in vivo acetylcholine release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900008-3

Selective D-1 dopamine receptor agonist treatment of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900008-3

Effects of classical and novel agents in a MPTP-induced reversible model of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900008-3

Drugs acting at D-1 and D-2 dopamine receptors induce identical purposeless chewing in rats which can be differentiated by cholinergic manipulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900008-3

Effect of chronic trifluoperazine administration and subsequent withdrawal on the production and persistence of perioral behaviours in two rat strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900008-3

Differential effect of systemic administration of bromocriptine and L-dopa on the release of acetylcholine from striatum of intact and 6-OHDA-treated rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900008-3

Pharmacological characterization of behavioural responses to SK&F 83959 in relation to 'D1-like' dopamine receptors not linked to adenylyl cyclase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900008-3

Modulatory functions of neurotransmitters in the striatum: ACh/dopamine/NMDA interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900008-3

Cholinergic-anticholinergic antagonism in parkinsonism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900008-3

Differential anti-parkinsonian effects of benzazepine D1 dopamine agonists with varying efficacies in the MPTP-treated common marmoset

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900008-3

Effects of dopaminergic stimulants on cyclic nucleotide levels in mouse brain in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900008-3

Does dopamine exert a tonic inhibitory control on the release of striatal acetylcholine in vivo?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900008-3

Differential efficacies of dopamine D1 receptor agonists for stimulating adenylyl cyclase in squirrel monkey and rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900008-3

Vacuous jaw movements and feeding deficits in rats with ventrolateral striatal dopamine depletion: possible relation to parkinsonian symptoms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900008-3

Multiple receptors for dopamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900008-3

Cholinergic stimulation of the ventrolateral striatum elicits mouth movements in rats: pharmacological and regional specificity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900008-3

Cholinergic/dopaminergic interaction in the rat striatum assessed from drug-induced repetitive oral movements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900008-3

The AMPA receptor antagonist NBQX has antiparkinsonian effects in monoamine-depleted rats and MPTP-treated monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900008-3

Glutamatergic drugs in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900008-3

Dopamine agonists in Parkinson's disease: a look at apomorphine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900008-3

D1 and D2 dopamine receptor interactions with pilocarpine-induced oral activity in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900008-3

The multiplicity of the D1 dopamine receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900008-3

Tremulous jaw movements produced by acute tacrine administration: possible relation to parkinsonian side effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900008-3

D2 dopamine receptors associated with inhibition of dopamine release from rat neostriatum are independent of cyclic AMP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900008-3

The induction of grooming and vacuous chewing by a series of selective D-1 dopamine receptor agonists: two directions of D-1:D-2 interaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900008-3

Agonist and antagonist properties of benzazepine and thienopyridine derivatives at the D1 dopamine receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900008-3

International guide to drugs for Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900008-3

Exacerbation of parkinsonism by tacrine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900008-3

A subpopulation of dopamine D1 receptors mediate repetitive jaw movements in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900008-3

Cholinergic manipulation of perioral behaviour induced by chronic neuroleptic administration to rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900008-3

Vacuous jaw movements induced by acute reserpine and low-dose apomorphine: possible model of parkinsonian tremor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900008-3

Behavioural and pharmacological characterization of the mouth movements induced by muscarinic agonists in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900008-3

Lateral striatal cholinergic mechanisms involved in oral motor activities in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900008-3

Enhanced striatal acetylcholine release by chlorpromazine and its reversal by apomorphine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900008-3

Effects of acute haloperidol and reserpine administration on vacuous jaw movements in three different age groups of rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900008-3

Vacuous jaw movements induced by sub-chronic administration of haloperidol: interactions with scopolamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900008-3

The pharmacological characterisation of pilocarpine-induced purposeless chewing behaviour in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900008-3

Assessment of the muscarinic receptor subtype involved in the mediation of pilocarpine-induced purposeless chewing behaviour

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900008-3

Dihydrexidine, a full dopamine D1 agonist, reduces MPTP-ioduced parkinsonism in monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900008-3

The selective dopamine D1 receptor agonist, SKF 81297, stimulates motor behaviour of MPTP-lesioned monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900008-3

The dopamine D1 agonist SKF 81297 and the dopamine D2 agonist LY 171555 act synergistically to stimulate motor behavior of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned parkinsonian rhesus monkeys.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900008-3

Dopamine D1 receptors: efficacy of full (dihydrexidine) vs. partial (SKF38393) agonists in primates vs. rodents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900008-3

Physostigmine test in the rabbit syndrome and tardive dyskinesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900008-3

10.1016/S0014-2999(97)00008-3

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9098680%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference